Shukra Pharmaceuticals Limited

Pharmaceutical company manufacturing and exporting various drugs and dosage forms globally.

1993 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Shukra Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 49.00 Cr
  • Paid Up Capital ₹ 43.79 Cr
  • Company Age 32 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 8.25 Cr
  • Satisfied Charges ₹ 15.92 Cr
  • Revenue Growth 28.91%
  • Profit Growth 320.68%
  • Ebitda 261.78%
  • Net Worth 127.85%
  • Total Assets 3.83%

About Shukra Pharmaceuticals

Shukra Pharmaceuticals Limited (SPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 04 March 1993 and has a history of 32 years and one month. Its registered office is in Ahmedabad, Gujarat.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524632.

The Corporate was formerly known as Relish Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 49.00 Cr and a paid-up capital of Rs 43.79 Cr.

The company currently has active open charges totaling ₹8.25 Cr. The company has closed loans amounting to ₹15.92 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Shukra Pharmaceuticals Limited India are Anar Patel as CFO and Arpita Kabra as Company Secretary. Shital Shah, Dakshesh Shah, Jitendra Shah, and Nine other members serve as directors at the Company.

Company Details

  • Location Ahmedabad, Gujarat
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24231GJ1993PLC019079

  • Company No.

    019079

  • Stock Symbol

    BSE : 524632

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    04 Mar 1993

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Shukra Pharmaceuticals Limited offer?

Shukra Pharmaceuticals Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Milk & Dairy Products, Milk Powder, Animal Medicines & Health Care, Veterinary Bolus, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Injectable Products.

Company report

Shukra Pharmaceuticals Limited

Explore comprehensive data for Shukra Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Shukra Pharmaceuticals?

Executive Team (3)

NameDesignationAppointment DateStatus
Dakshesh Shah Country flag representing In Managing Director26-May-2012Current
Anar Patel CFO09-Aug-2024Current
Arpita Kabra Country flag representing In Company Secretary04-Jan-2021Current

Board Members (11)

NameDesignationAppointment DateStatus
Anar Patel Country flag representing In Whole-Time Director 10-Jul-2024Current
Shital Shah Country flag representing In Whole-Time Director 25-Oct-2024Current
Jitendra Shah Country flag representing In Director 10-Jul-2024Current
Payal Mehta Country flag representing In Director 23-May-2012Current
Sanskruti Patel Country flag representing In Whole-Time Director 16-Aug-2023Current
Sonal Gandhi Country flag representing In Director 12-Aug-2023Current

Financial Performance of Shukra Pharmaceuticals.

Shukra Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 28.91% increase. The company also saw a substantial improvement in profitability, with a 320.68% increase in profit. The company's net worth Soared by an impressive increase of 127.85%.

Shukra Pharmaceuticals revenue growth over time
Shukra Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
28.91%
Revenue from Operations
26.75%
Total Assets
3.83%
Profit or Loss
320.68%
Net Worth
127.85%
EBITDA
261.78%

What is the Ownership and Shareholding Structure of Shukra Pharmaceuticals?

In 2024, Shukra Pharmaceuticals had a promoter holding of 50.95% and a public holding of 49.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹8.25 Cr

Satisfied Charges

₹15.92 Cr

Charges Breakdown by Lending Institutions

  • Others : 6.00 Cr
  • Tata Capital Financial Services Limited : 2.25 Cr

Latest Charge Details

DateLenderAmountStatus
06 Sep 2024Others₹6.00 CrOpen
16 Dec 2022Tata Capital Financial Services Limited₹7.50 MOpen
28 Dec 2020Tata Capital Financial Services Limited₹1.50 CrOpen
31 Dec 2016Hdfc Bank Limited₹3.25 CrSatisfied
03 Jan 2000Union Bank Of India₹3.20 MSatisfied

How Many Employees Work at Shukra Pharmaceuticals?

Shukra Pharmaceuticals has a workforce of 99 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Shukra Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shukra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shukra Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Shukra Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Shital Dakshesh Shah was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 25 Oct 2024 & has been associated with this company since 6 months 7 days .

  • Director Appointment

    Ritu Kapoor was appointed as a Director was appointed as a Director on 25 Oct 2024 & has been associated with this company since 6 months 7 days .

  • Annual General Meeting

    Shukra Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Charges

    A charge with Others of Rs. 6.00 Cr registered on 06 Sep 2024 with Charge ID 100970269 was modified on 13 Sep 2024.

  • Charges

    A charge with Others amounted to Rs. 6.00 Cr with Charge ID 100970269 was registered on 06 Sep 2024.

  • Director Appointment

    Anar Jayeshbhai Patel was appointed as a Cfo was appointed as a Cfo on 09 Aug 2024 & has been associated with this company since 8 months 22 days .

Frequently asked questions

  • What is the Incorporation or founding date of Shukra Pharmaceuticals Limited?

    Shukra Pharmaceuticals Limited was incorporated on 04 Mar 1993.

  • What is authorized share capital and paid-up capital of Shukra Pharmaceuticals Limited?

    The authorized share capital of Shukra Pharmaceuticals Limited is ₹ 49.00 Cr and paid-up capital is ₹ 43.79 Cr.

  • Who are the current board members & directors of Shukra Pharmaceuticals Limited?

    Currently 14 directors are associated with Shukra Pharmaceuticals Limited.

    • Shital Dakshesh Shah
    • Dakshesh Rameshchandra Shah
    • Jitendra Somchand Shah
    • Payal Sujay Mehta
    • Anar Jayeshbhai Patel
    • Sanskruti Jayeshbhai Patel
    • Sonal Deepalbhai Gandhi
    • Pinki Nirmal Sagar
    • Sarjeevan Singh
    • Bhoomiben Patel
    • Dhruvin Shah
    • Ritu Kapoor
    • Anar Jayeshbhai Patel
    • Arpita Kabra

  • What is the registered address of Shukra Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Shukra Pharmaceuticals Limited is 3Rd Floor Dev House Opp. Wiaa Office Judges Bungalows Road Bodakdev, India, Ahmedabad, Gujarat, 380003.

  • What is the corporate identification number (CIN) and company number of Shukra Pharmaceuticals Limited?

    The corporate identification number (CIN) of Shukra Pharmaceuticals Limited is L24231GJ1993PLC019079 and the company number is 019079 as per Ministry of Corporate Affairs (MCA).

  • Is Shukra Pharmaceuticals Limited registered with any stock exchange in India?

    Yes, Shukra Pharmaceuticals Limited is registered on Bombay Stock Exchange (BSE).

  • What is the official website of Shukra Pharmaceuticals Limited?

    The Official website of Shukra Pharmaceuticals Limited is https://www.shukrapharmaceuticals.com

  • What has been the recent revenue trend for Shukra Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Shukra Pharmaceuticals Limited has risen by 28.91%.

  • How many employees does Shukra Pharmaceuticals Limited currently have?

    As Per 2024 financial reports, 99 employees are currently employed by Shukra Pharmaceuticals Limited.

  • What change has been observed in the net worth of Shukra Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Shukra Pharmaceuticals Limited has experienced an upsurge of 127.85%.

  • What are the total open charges for Shukra Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Shukra Pharmaceuticals Limited amount to ₹ 8.25 Cr.

  • When was the last Balance Sheet of Shukra Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Shukra Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development